Phacilitate Leaders World

Sponsors & Exhibitors

BioSpherix

Total quality recognizes that for best cell potency, cells need full-time optimization of all critical cell process parameters, during incubation, and also during handling and processing upstream and downstream of incubation.

Total quality recognizes that all typical negative side effects of machines on cells (particles, heat, vibration, etc.) must be neutralized to make automation compatible with a cell optimized ecosystem.

Total quality recognizes that each batch must have a complete end-to-end secure batch record of all critical process parameters and all critical environmental parameters.

Total quality recognizes that unlimited numbers of batches must be producible simultaneously side-by-side (massively parallel) with 0% cross contamination risk and dispersed globally with 0% variance risk and evidence to prove it.

Total quality recognizes that scaling up and out must be efficient with 0% variance risk and evidence to prove it.

Total quality recognizes that validation of new production capacity regardless of scale or location must be 100% reliable and fast (within days) and quick and easy to move, to different locations globally or locally as needed (within weeks).

 

Visit Website
View all Sponsors & Exhibitors
Loading
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK